• vs. potential COVID-19 treatments
• vs. anti-inflammatoty and immuno-therapy
• vs. Immunostimulants drugs
• vs. interferon
• vs. Immunosuppressants drugs
• vs. anti-interleukin-6
• vs. tocilizumab
• vs. antiviral and associated therapy
• vs. chloroquine and derivatives
• vs. chloroquine
• vs. hydroxychloroquine
• vs. favipiravir
• vs. lopinavir/ritonavir
• vs. umifenovir (arbidol)
• vs. control
• vs. placebo
• vs. standard of care

  patient subgroup...     Top evidence (RCT only, high risk of bias excluded) Best available evidence (possibly low or very low) All RCTs All studies (RCT+OBS)

select an endpoint to display result.... display studies ---- color = results color = ROB demonstrated suggested inconclusive safety concern ongoing study not assessable low moderate serious ongoing study display ongoing demontrated benefit only